Relmada Therapeutics Inc (STU:4E2) Stock News, Headlines & Updates
Relmada Therapeutics Inc Stock News from GuruFocus
- 1
Jul 15, 2025
Relmada Therapeutics (RLMD) Appoints New Chair for Clinical Advisory Board | RLMD Stock News
GuruFocus News • 7:45am
Relmada Therapeutics Appoints Renowned Urologic Oncologist, Yair Lotan, MD, to Chair the Clinical Advisory Board and Support Development of NDV-01
Marketwired • 7:00am
Jul 09, 2025
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
Marketwired • 7:00am
Jun 17, 2025
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology | RLMD Stock News
GuruFocus News • 6:22am
Relmada Therapeutics (RLMD) Appoints New Chief Medical Officer | RLMD Stock News
GuruFocus News • 6:17am
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
Marketwired • 6:00am
May 13, 2025
Relmada Therapeutics Inc (RLMD) Q1 2025 Earnings Call Highlights: Promising Pipeline Developments Amid Financial Challenges
GuruFocus News • 1:09am
Q1 2025 Relmada Therapeutics Inc Earnings Call Transcript
GuruFocus News • 11:02pm
May 12, 2025
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Marketwired • 4:00pm
May 08, 2025
Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
Marketwired • 7:00am
Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 | RLMD Stock News
GuruFocus News • 6:53am
Apr 28, 2025
Relmada Therapeutics (RLMD) Reports Promising Phase 2 Results for NDV-01 in Bladder Cancer | RLMD Stock News
GuruFocus News • 1:15pm
Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
Marketwired • 1:00pm
Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025 | RLMD Stock News
GuruFocus News • 12:45pm
Apr 27, 2025
Relmada Therapeutics (RLMD) to Discuss NDV-01 Phase 2 Study Results in Virtual Meeting | RLMD Stock News
GuruFocus News • 5:16pm
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire • 11:00am
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025 | RLMD Stock News
GuruFocus News • 8:15am
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
Marketwired • 8:00am
Apr 24, 2025
Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news